Johnson & Johnson buy Wells Fargo & Company
Start price
13.12.25
/
50%
€180.28
Target price
13.12.26
€195.96
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 13.12.26. The prediction end date can be changed by Wells_Fargo___Compan at any time.Johnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
Performance without dividends (%)
| Name | 1w |
|---|---|
| Johnson & Johnson | - |
| iShares Core DAX® | 0.734% |
| iShares Nasdaq 100 | -2.686% |
| iShares Nikkei 225® | -2.261% |
| iShares S&P 500 | -1.346% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Johnson & Johnson diskutieren
Johnson & Johnson (NYSE:JNJ) had its price target raised by analysts at Wells Fargo & Company from $212.00 to $230.00. They now have an "overweight" rating on the stock.
Ratings data for JNJ provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Johnson & Johnson
Johnson & Johnson
Start price
Target price
Perf. (%)
€161.00
04.10.25
04.10.25
€180.56
04.10.26
04.10.26
11.98%
12.12.25
12.12.25
